You are here

New Study to Look at COVID-19 Vaccine Uptake, Side Effects in At-Risk Groups

Research by the BC Centre on Substance Use at St. Paul’s Hospital and other groups has received $770,000 to investigate the uptake, effectiveness and side effects of COVID-19 vaccines among vulnerable urban populations.

Urban centres across Canada are home to many groups who are more at risk of acquiring SARS-CoV-2 and developing serious complications from COVID-19.

The Government of Canada, through the COVID-19 Immunity Task Force (CITF) and the Vaccine Surveillance Reference Group (VSRG), is funding the study.

Participants to include those who experience homelessness, poverty, incarceration

The people to be included in this study experience risk factors such as homelessness and poverty, may live in social housing or correctional facilities, may use drugs intensively or have additional health conditions due to compromised immune systems, or may have poor nutrition, hygiene or inadequate living conditions. Adding to these risks are the barriers to vaccination, ranging from stigma to discrimination, which they already often face when trying to access healthcare.

Researchers to recruit 250 people from three Vancouver cohorts

Researchers will recruit more than 250 people who use drugs from three community-recruited cohorts in Vancouver, British Columbia. Researchers aim to assess vaccine uptake, adherence to vaccination protocols, as well as monitor and investigate potential side effects of the vaccines. It is anticipated that the results from this study, combined with data from other relevant COVID-19 studies across Canada, will contribute to a better understanding of vaccines and Canada’s vulnerable population.

Read the full article here at The Daily Scan | New Study to Look at COVID-19 Vaccine Uptake, Side Effects in At-Risk Groups